anokion
Astellas spending $760m on autoimmune tie-up
June 4, 2015Sales and Marketing Astellas, anokion, brett wells, kanyos
Astellas Pharma and Anokion are to collaborate and develop new treatments for type 1 diabetes and celiac disease in a deal that could net …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
